Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Lamberts

Lamberts

posted on Sep 17, 2008 04:56PM

As per the PRER14A out today the amount of voting shares has changed.......

As of the record date, we had 387,047,755 shares of common stock, $0.00001 par value per share (“Common Stock”), outstanding and entitled to vote.

IR has informed me the Crossflo shares are not eligible to vote........

Share
New Message
Please login to post a reply